Dexmedetomidine’s Effect on Catecholamine and Inflammation in Reducing In-Hospital Adverse Events for Older Patients with STEMI Undergoing Primary PCI
DEX was associated with lower catecholamine and inflammation levels, provided adequate sedation, and appeared safety, feasibility, and effectiveness for older patients with STEMI undergoing primary PCI.
Authors
- Guang-An Liu (ORCID: https://orcid.org/0009-0004-2040-5643)
- Lingxiao Zhou (ORCID: https://orcid.org/0000-0002-2004-0929)
- Weihua Wu (ORCID: https://orcid.org/0000-0002-5824-7781)
- Ruoxi Zhang (ORCID: https://orcid.org/0000-0003-3331-229X)
- Feng Liu
Institutions
- Suzhou Kowloon Hospital (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/dddt.s542160
- Citations
- 1
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 2.19
Funders
- Shanghai Jiao Tong University
- School of Medicine, Shanghai Jiao Tong University
- Science and Technology Program of Suzhou